Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus

Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus

Objective: Recently approved direct acting antivirals provide transformative therapies for chronic hepatitis C virus (HCV) infection. The major clinical challenge remains to identify the undiagnosed patients worldwide, many of whom live in low-income and middle-income countries, where access to nucl...

Full description

Bibliographic Details
Main Authors: Llibre, Alba, Shimakawa, Yusuke, Mottez, Estelle, Ainsworth, Shaun, Buivan, Tan-Phuc, Firth, Rick, Harrison, Elliott, Rosenberg, Arielle R., Meritet, Jean-Francois, Fontanet, Arnaud, Castan, Pablo, Madejon, Antonio, Laverick, Mark, Glass, Allison, Viana, Raquel, Pol, Stanislas, McClure, C. Patrick, Irving, William Lucien, Miele, Gino, Albert, Matthew L., Duffy, Darragh
Format: Article
Language:English
Published: BMJ Publishing Group 2018
Online Access:https://eprints.nottingham.ac.uk/51091/

Internet

https://eprints.nottingham.ac.uk/51091/

Similar Items